title: Liver transplantation and hepatitis C: will understanding the interleukin-28B polymorphisms improve outcomes?
authors.forename: Geoffrey W
authors.initials: GW
authors.lastname: McCaughan
authors.forename: Nicholas A
authors.initials: NA
authors.lastname: Shackel
authors.forename: David G
authors.initials: DG
authors.lastname: Bowen
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use; D020022:Genetic Predisposition to Disease; D006084:Graft Rejection / Q000235:genetics* / Q000276:immunology / Q000517:prevention & control; D006085:Graft Survival / Q000187:drug effects / Q000235:genetics*; D006526:Hepatitis C / Q000175:diagnosis / Q000188:drug therapy / Q000235:genetics* / Q000276:immunology; D006801:Humans; D007372:Interferons; D007378:Interleukins / Q000235:genetics*; D008103:Liver Cirrhosis / Q000235:genetics / Q000276:immunology; D016031:Liver Transplantation / Q000276:immunology*; D011110:Polymorphism, Genetic; D012008:Recurrence; D018570:Risk Assessment; D012307:Risk Factors; D012720:Severity of Illness Index; D013997:Time Factors; D016896:Treatment Outcome; D000095022:Interferon Lambda
chemical_list: D000998:Antiviral Agents; D007372:Interferons; D007378:Interleukins; C000624353:interferon-lambda, human; D000095022:Interferon Lambda